P. Gérard

Preclinical tolerance evaluation of the addition of a cisplatin-based dry powder for inhalation to the conventional carboplatin-paclitaxel doublet for treatment of non-small cell lung cancer.

K. Amighi, M. Remmelink, N. Wauthoz, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model.

M. Moser, O. Leo, K. Amighi, 2022, Journal of controlled release : official journal of the Controlled Release Society.

Thermal-vacuum and security system of the characterization facility for MAJIS/JUICE VIS-NIR FM and SM detectors

Nuno Pereira, François Poulet, Özgür Karatekin, 2020, Astronomical Telescopes + Instrumentation.